» Articles » PMID: 31316986

Improvement in Tuberculosis Outcomes With a Combined Medical and Social Approach

Overview
Specialty General Medicine
Date 2019 Jul 19
PMID 31316986
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Studies performed locally in Switzerland in the late eighties reported unsatisfactory treatment outcomes. Better outcomes were observed since the introduction of directly observed therapy (DOT) in the late nineties and improvement in social support in recent years. retrospective study of treatment outcomes for all tuberculosis (TB) patients notified in Vaud County (VD), Switzerland, between, 1st of January 2010 and 31st of December of 2014. 375 patients were notified in VD during the study period. The global outcome was successful in 90.1% of patients (338/375). In 183 culture and PCR positive pulmonary TB, the documented cure rate was 57.9% (106/183), and the treatment completion was 59/183 (32.2%), i.e., a treatment success of 90.2%. DOT was applied globally in 234/375 (62.4%) and in 64/67 of the asylum seekers (AS) (95.5%) followed at the dispensary. Treatment outcomes were successful in 60/67 (89.6%) AS. Improvements in tuberculosis outcomes resulted not only from the introduction of DOT in VD in the nineties but also from a change in the management, with increased attention to the social problems faced by the migrants. A combined medical and social approach of TB care in VD improved treatment outcomes.

Citing Articles

Tuberculosis in adult migrants in Europe: a TBnet consensus statement.

Kunst H, Lange B, Hovardovska O, Bockey A, Zenner D, Andersen A Eur Respir J. 2024; 65(3).

PMID: 39672603 PMC: 11883149. DOI: 10.1183/13993003.01612-2024.


Evaluation of drug-resistant tuberculosis treatment outcome in Limpopo province, South Africa.

Seloma N, Makgatho M, Maimela E Afr J Prim Health Care Fam Med. 2023; 15(1):e1-e7.

PMID: 37526555 PMC: 10476443. DOI: 10.4102/phcfm.v15i1.3764.


Tuberculosis in migrants - screening, surveillance and ethics.

Scandurra G, Degeling C, Douglas P, Dobler C, Marais B Pneumonia (Nathan). 2020; 12:9.

PMID: 32923311 PMC: 7473829. DOI: 10.1186/s41479-020-00072-5.


Tuberculosis among economic migrants: a cross-sectional study of the risk of poor treatment outcomes and impact of a treatment adherence intervention among temporary residents in an urban district in Ho Chi Minh City, Viet Nam.

Vo L, Codlin A, Forse R, Nguyen H, Vu T, Van Truong V BMC Infect Dis. 2020; 20(1):134.

PMID: 32050913 PMC: 7017549. DOI: 10.1186/s12879-020-4865-7.


Whole-genome sequencing for rapid, reliable and routine investigation of transmission in local communities.

Zakham F, Laurent S, Esteves Carreira A, Corbaz A, Bertelli C, Masserey E New Microbes New Infect. 2019; 31:100582.

PMID: 31388433 PMC: 6669808. DOI: 10.1016/j.nmni.2019.100582.

References
1.
Volmink J, Matchaba P, Garner P . Directly observed therapy and treatment adherence. Lancet. 2000; 355(9212):1345-50. DOI: 10.1016/S0140-6736(00)02124-3. View

2.
Rajagopalan S . Tuberculosis and aging: a global health problem. Clin Infect Dis. 2001; 33(7):1034-9. DOI: 10.1086/322671. View

3.
Helbling P, Medinger C, Altpeter E, Beeli D, Zellweger J . Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Med Wkly. 2002; 132(35-36):517-22. DOI: 10.4414/smw.2002.10045. View

4.
Deruaz J, Zellweger J . Directly observed therapy for tuberculosis in a low prevalence region: first experience at the Tuberculosis Dispensary in Lausanne. Swiss Med Wkly. 2004; 134(37-38):552-8. DOI: 10.4414/smw.2004.10643. View

5.
Guglielmi S, Barben J, Horn L, Schoch O . Administrative monitoring of tuberculosis treatment in Switzerland. Int J Tuberc Lung Dis. 2006; 10(11):1236-40. View